Security
BIOTW · Biotech Acquisition Co
BIOTWNASDAQWarrantHistorical · closed Feb 2, 2023CIK 1825413Updated Sep 24, 2026
Name history
Biotech Acquisition Company · through Sep 21, 2020
BIOTW price & chart
Historical security
This listing closed Feb 2, 2023. Live provider charts are shown only for current listings.
In the news
No coverage from other publishers is available.
Recent filings
Show 5 more recent filings
Financials
FY 2021 · USDSource
Source
balance sheet · annual statements
| Line item | FY 2021 | FY 2020 |
|---|---|---|
| ASSETS | ||
| AssetsUSD | 230,320,701Source | 89,500Source |
| Current assets: | ||
| Cash and Cash Equivalents, at Carrying ValueUSD | 91,407Source | — |
| Assets, CurrentUSD | 299,463Source | — |
| LIABILITIES AND EQUITY | ||
| LiabilitiesUSD | 27,469,212Source | — |
| Stockholders’ equity: | ||
| Common Stock, Value, IssuedUSD | 575Source | — |
| Additional Paid in CapitalUSD | — | 24,425Source |
| Retained Earnings (Accumulated Deficit)USD | -27,170,324Source | -5,000Source |
| Stockholders' Equity Attributable to ParentUSD | -27,169,749Source | 20,000Source |
| Liabilities and EquityUSD | 230,320,701Source | 89,500Source |
| Current liabilities: | ||
| Liabilities, CurrentUSD | 313,812Source | 69,500Source |
cash flow · annual statements
| Line item | FY 2021 |
|---|---|
| Cash flows from operating activities: | |
| Net Income (Loss), Including Portion Attributable to Noncontrolling InterestUSD | -6,864,581Source |
| Net Cash Provided by (Used in) Operating ActivitiesUSD | -1,465,214Source |
| Cash flows from investing activities: | |
| Net Cash Provided by (Used in) Investing ActivitiesUSD | -230,000,000Source |
| Cash flows from financing activities: | |
| Net Cash Provided by (Used in) Financing ActivitiesUSD | 231,556,621Source |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash EquivalentsUSD | 91,407Source |
| Additional Financial Items | |
| Investment Income, InterestUSD | 21,238Source |
| Net Income (Loss) Attributable to ParentUSD | -6,864,581Source |
| Operating Costs and ExpensesUSD | 1,570,165Source |
| Payments of Financing CostsUSD | 374,749Source |
| Stock or Unit Option Plan ExpenseUSD | 520,319Source |